Stocktwits on MSN3d
Regeneron Stock Down 30% Over Past 6 Months: Leerink Sees Buying Opportunity, Retail's On The Same Page
Shares of Regeneron Pharmaceuticals have plunged more than 30% over the past six months, but one Wall Street analyst believes ...
Leerink Partners Upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Outperform
Leerink Partners upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a market perform rating to an ...
Regeneron upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Regeneron (REGN) to Outperform from Market Perform with a price target of $834, up from $762. The shares have fallen 35% over ...
ETF Daily News2d
Regeneron Pharmaceuticals (NASDAQ:REGN) Raised to “Strong-Buy” at Leerink Partnrs
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) was upgraded by stock analysts at Leerink Partnrs from a “hold” rating to a “strong-buy” rating in a research report issued to ...
Nasdaq4d
Leerink Partners Upgrades Regeneron Pharmaceuticals (LSE:0R2M)
Fintel reports that on February 5, 2025, Leerink Partners upgraded their outlook for Regeneron Pharmaceuticals (LSE:0R2M) from Market Perform to Outperform. There are 2,471 funds or institutions ...
RBC Capital Reaffirms Their Buy Rating on Regeneron (REGN)
In a report released yesterday, Brian Abrahams from RBC Capital maintained a Buy rating on Regeneron (REGN – Research Report), with a price ...
AMD, Spotify downgraded: Wall Street's top analyst calls
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
Nasdaq4d
Leerink Partners Upgrades Regeneron Pharmaceuticals (WBAG:REGN)
Fintel reports that on February 5, 2025, Leerink Partners upgraded their outlook for Regeneron Pharmaceuticals (WBAG:REGN) from Market Perform to Outperform. There are 2,472 funds or institutions ...